CLINICAL_TRIALS
trial_result
· 2025-05-25
Clinical Trial Update: Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Summary
A phase 2 trial of the anti-PD-L1 agent avelumab in newly diagnosed glioblastoma multiforme has completed enrollment and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Clinique Neuro-Outaouais | Conditions: Glioblastoma Multiforme of Brain | Phase 2 | Status: COMPLETED | Results posted: 2025-05-25